FADS1, a lipid metabolism-related diagnostic biomarker in KIRC

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Kidney renal clear cell carcinoma (KIRC) is a major subtype of renal cell carcinoma with poor prognosis.
• Current targeted therapies for KIRC often face resistance, necessitating novel biomarkers and therapeutic targets.
• The fatty acid desaturase 1 (FADS1) gene, involved in lipid metabolism, has an under-explored role in KIRC.

Purpose of the Study:

• To investigate the expression levels and functional role of FADS1 in KIRC.
• To explore the association between FADS1 expression and clinical pathological features, immune infiltration, and patient prognosis.
• To evaluate FADS1 as a potential diagnostic and therapeutic target for KIRC.

Main Methods:

• Bioinformatics analysis using TCGA database and other platforms to assess FADS1 expression.
• Quantitative PCR (qPCR) and Western blot analysis on KIRC clinical tissue samples for validation.
• Statistical analyses including Wilcoxon rank sum test and Kaplan-Meier analysis.
• In vitro experiments to confirm the biological functions of FADS1.

Main Results:

• FADS1 is significantly upregulated in KIRC tissues and correlates with tumor development.
• Elevated FADS1 expression is linked to increased lipid accumulation within tumor cells.
• TIMER analysis revealed a significant correlation between FADS1 expression and the infiltration levels of various immune cells in the KIRC microenvironment.

Conclusions:

• FADS1 functions as an oncogene in KIRC, promoting tumor progression through lipid metabolism.
• FADS1 expression is associated with immune cell infiltration, suggesting a role in modulating the tumor immune microenvironment.
• FADS1 holds potential as a prognostic biomarker and a therapeutic target for KIRC, warranting further investigation into its mechanisms.